Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Kindred Healthcare, Inc. (KND) Hedge Funds Are Snapping Up

Page 1 of 2

Hedge funds run by legendary names like Nelson Peltz and David Tepper make billions of dollars a year for themselves and their super-rich accredited investors (you’ve got to have a minimum of $1 million liquid to invest in a hedge fund) by spending enormous resources on analyzing and uncovering data about small-cap stocks that the big brokerage houses don’t follow. Small caps are where they can generate significant out-performance. That’s why we pay special attention to hedge fund activity in these stocks.

Kindred Healthcare, Inc. (NYSE:KND) has seen an increase in hedge fund interest lately. The level and the change in hedge fund popularity aren’t the only variables you need to analyze to decipher hedge funds’ perspectives. A stock may witness a boost in popularity, but it may still be less popular than similarly priced stocks. That’s why at the end of this article, we will examine companies such as CONMED Corporation (NASDAQ:CNMD), Brink’S Co (NYSE:BCO), and RealPage, Inc. (NASDAQ:RP) to gather more data points.

Follow Kindred Healthcare Inc (NYSE:KND)
Trade (NYSE:KND) Now!

To the average investor, there are several metrics stock market investors can use to size up their holdings. A pair of the most underrated metrics are hedge fund and insider trading indicators. Our researchers have shown that, historically, those who follow the top picks of the top hedge fund managers can outclass the market by a superb margin (see the details here).

Now, we’re going to take a look at the latest action surrounding Kindred Healthcare, Inc. (NYSE:KND).

How have hedgies been trading Kindred Healthcare, Inc. (NYSE:KND)?

At the end of September, a total of 35 of the hedge funds tracked by Insider Monkey were long this stock, an increase of 9% from the previous quarter. With hedge funds’ capital changing hands, there exists a few key hedge fund managers who were increasing their holdings substantially (or already accumulated large positions).

Of the funds tracked by Insider Monkey, Conan Laughlin’s North Tide Capital has the biggest position in Kindred Healthcare, Inc. (NYSE:KND), worth close to $78.8 million, accounting for 6.9% of its total 13F portfolio. Sitting at the No. 2 spot is Ross Margolies of Stelliam Investment Management, with a $58.3 million position; the fund has 1.4% of its 13F portfolio invested in the stock. Other professional money managers with similar optimism encompass Clint Carlson’s Carlson Capital, Don Morgan’s Brigade Capital, and Jacob Gottlieb’s Visium Asset Management.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!